Matica Biotechnology
Matica Biotechnology is a viral vector and gene therapy Contract Development and Manufacturing Organization (CDMO) that leverages advanced technologies at its purpose-built cGMP facility. With industry-leading expertise in process development, assay development, and cGMP manufacturing, Matica Bio serves as a trusted partner, supporting clients throughout every stage of virus-based projects. The company is committed to delivering innovative medicines from idea to patient, with a vision to be a trusted global leader in manufacturing lifesaving therapies.
Industries
Nr. of Employees
medium (51-250)
Matica Biotechnology
College Station, Texas, United States, North America
Products
Proprietary stable producer cell line platform
A platform of optimized stable producer cell lines designed to enable sustained and scalable viral vector production for manufacturing workflows.
Proprietary stable producer cell line platform
A platform of optimized stable producer cell lines designed to enable sustained and scalable viral vector production for manufacturing workflows.
Services
Development and optimization of producer and suspension cell lines for viral vector generation, including strategies for stable producer cell lines.
End-to-end process design and optimization for upstream cell culture and downstream purification to enable clinical and commercial production.
Design and validation of assays for identity, potency, purity, safety and stability to support product characterization and regulatory submissions.
cGMP manufacturing of virus-based products using purpose-built facilities and compliant operations for clinical and commercial material supply.
Quality systems, release testing, stability testing and other QC functions to support product release and regulatory submissions.
Development and optimization of producer and suspension cell lines for viral vector generation, including strategies for stable producer cell lines.
End-to-end process design and optimization for upstream cell culture and downstream purification to enable clinical and commercial production.
Design and validation of assays for identity, potency, purity, safety and stability to support product characterization and regulatory submissions.
cGMP manufacturing of virus-based products using purpose-built facilities and compliant operations for clinical and commercial material supply.
Quality systems, release testing, stability testing and other QC functions to support product release and regulatory submissions.
Expertise Areas
- Viral vector manufacturing and CDMO services
- Cell line and vector development
- Upstream and downstream process development
- Analytical development and QC testing for viral vectors
Key Technologies
- Viral vector production (AAV, lentiviral and similar platforms)
- Stable producer cell line platforms
- Single-use bioprocessing
- Microcarrier-based cell culture
News & Updates
June 16-19, 2025, Boston, MA
October 6-8, 2025, Phoenix, AZ
Vector projects completed
Over 300 vector projects completed.
Average industry experience
Over 15 years of average experience in the biotech industry.
June 16-19, 2025, Boston, MA
October 6-8, 2025, Phoenix, AZ
Vector projects completed
Over 300 vector projects completed.
Average industry experience
Over 15 years of average experience in the biotech industry.